U

UroGen Pharma, Inc

Develops RTGel-based drug delivery for uro-oncology

Director Clinical Operations

Clinical Research OperationsConfirmed live in the last 24 hours
Full-timeUnited States$200k - $220k /yr

About the Job

Requirements

  • A bachelor's or master's degree in life sciences, or equivalent qualifications.
  • At least 10 years of progressive clinical operations experience in the pharmaceutical or biotech industry.
  • Demonstrated experience serving as the accountable operational lead for a large, complex global Phase 3 clinical study, with responsibility for cross-functional execution, CRO oversight, study timelines, budgets, and risk management.
  • Experience managing clinical trials across the study lifecycle, including startup, enrollment, ongoing conduct, and closeout.
  • Strong knowledge of FDA requirements, ICH guidelines, Good Clinical Practice, ethics requirements, applicable country regulations, Trial Master File management, and clinical trial quality requirements.
  • Working knowledge of data management, clinical data review and analysis, and pharmacovigilance; proficiency with IxRS/IRT, CTMS, and EDC systems.
  • Demonstrated ability to lead and develop staff, influence cross-functional teams, and manage external partners across geographies, cultures, and time zones.
  • Ability to travel up to 20%.

Responsibilities

  • Serve as Project Director and primary operational lead for a large, global Phase 3 study, driving execution from planning and startup through enrollment, study conduct, and closeout.
  • Lead the cross-functional study team, establish clear responsibilities and decision processes, and coordinate activities across internal functions, CROs, vendors, countries, and sites.
  • Develop and maintain integrated study plans, timelines, enrollment forecasts, and budgets; identify dependencies and drive delivery of key milestones.
  • Lead CRO and vendor identification, evaluation, selection, and oversight. Establish performance expectations, monitor delivery against scope and milestones, and address performance issues promptly.
  • Partner with Finance to manage study budgets, financial forecasts, vendor and site contracts, and change orders, ensuring operational needs and financial commitments remain aligned.
  • Provide Clinical Operations input into clinical development plans and protocol design, assessing operational feasibility, study procedures, visit schedules, site and patient burden, and recruitment considerations.
  • Lead operational assessments of protocol amendments and incorporate resulting changes into study plans, vendor scopes, training, timelines, and budgets.
  • Develop country and site strategies and patient recruitment plans. Monitor activation, screening, enrollment, and retention, and implement actions to address shortfalls.
  • Establish study metrics and reporting that make performance, risks, and decisions visible. Interpret trends, develop action plans, and follow through to resolution.
  • Identify and mitigate operational risks, maintain contingency plans, and escalate issues with clear recommendations and their implications for timelines, quality, and cost.
  • Partner with Data Management, Biostatistics, and Pharmacovigilance to support timely data collection, review, analysis, and reporting, and coordinate operational activities supporting database lock.
  • Maintain continuous inspection readiness, including a complete and current Trial Master File, appropriate sponsor oversight documentation, and timely resolution of quality issues.
  • Ensure study execution complies with UroGen SOPs, Good Clinical Practice, and applicable country requirements. Support audits, inspections, and corrective and preventive actions with Quality Assurance.
  • Coach and develop clinical operations staff responsible for study delivery and ensure effective coordination across locations and time zones.
  • Contribute to the growth of Clinical Operations by developing practical processes, systems, and infrastructure and applying industry best practices to improve study execution.

Desired Qualifications

  • Oncology clinical trial experience is strongly preferred.
  • Urology or uro-oncology experience is preferred but not required.

About the Company

UroGen Pharma, Inc

Develops RTGel-based drug delivery for uro-oncology

UroGen Pharma develops RTGel-based drug-delivery therapies for urothelial and specialty cancers, commercializing products like Jelmyto and ZUSDURI and advancing a pipeline that includes UGN-102, UGN-103, UGN-104, and UGN-301. Its RTGel platform is liquid at cool temperatures and gels at body temperature, allowing chemotherapy to stay at the treatment site longer for local, sustained exposure. The company differentiates itself by delivering established chemotherapy directly to the disease site to reduce systemic exposure and by building a multi-product portfolio focused on urothelial cancers. Its goal is to improve local treatment outcomes and grow a diversified, globally commercial portfolio through ongoing clinical development and partnerships.

Company size
201-500
Company stage
IPO
Headquarters
Princeton, NJ
Founded
2004

Recently Posted Jobs

Explore more opportunities at UroGen Pharma, Inc

See more jobs